ScholarWorks@Gyeongsang National University

Browsing by Kang, Hye JinAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 14 of 14

SCISCIESCOPUS
Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

Lee, Sung Sook; Suh, Cheolwon; Kim, Bong-Seog; Chung, Jooseop; Joo, Young-Don; Ryoo, Hun-Mo; Do, Young Rok; Jin, Jong-Youl; Kang, Hye Jin; Lee, Gyeong-Won, et al.

ArticleIssue Date2010CitationANNALS OF HEMATOLOGY, v.89, no.9, pp 905 - 912PublisherSPRINGER
SCIESCOPUS
Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma

Park, Byeong-Bae; Kim, Jin Seok; Lee, Young-Yuel; Kang, Hye Jin; Ryoo, Baek Yeol; Kang, Jung Hun; Kim, Ho Young; Kim, Bong-Seog; Oh, Sung Yong; Kwon, Hyuk Chan, et al.

ArticleIssue Date2008CitationLEUKEMIA & LYMPHOMA, v.49, no.1, pp 88 - 94PublisherTAYLOR & FRANCIS LTD
SCIESCOPUS
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry

Kim, Seok Jin; Kim, Kihyun; Kim, Byung Soo; Jo, Deog-Yeon; Kang, Hye Jin; Kim, Jin Seok; Mun, Yeung-Chul; Kim, Chul Soo; Sohn, Sang Kyun; Eom, Hyeon-Seok, et al.

ArticleIssue Date2009CitationACTA HAEMATOLOGICA, v.122, no.4, pp 200 - 210PublisherKARGER
SCIESCOPUS
Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma

Lee, Gyeong-Won; Go, Se-Il; Kim, Seok-Hyun; Hong, Junshik; Kim, Yu Ri; Oh, Sukjoong; Kim, Sung-Yong; Do, Young Rok; Lee, Hyewon; Lee, Soon Il, et al.

ArticleIssue Date2015CitationLEUKEMIA & LYMPHOMA, v.56, no.4, pp 1020 - 1026PublisherTAYLOR & FRANCIS LTD
SCIESCOPUS
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantationopen access

Kim, Seok Jin; Jo, Jae-Cheol; Yoon, Dok Hyun; Yang, Deok-Hwan; Yoon, Sang Eun; Lee, Gyeong-Won; Kong, Jee Hyun; Park, Yong; Kang, Ka-Won; Lee, Ho-Sup, et al.

ArticleIssue Date2023CitationFrontiers in Oncology, v.13PublisherFrontiers Media S.A.
SCISCIESCOPUS
Current Treatment Patterns and Outcomes in Patients with Peripheral T-Cell Lymphoma: Updated Results of the Nationwide, Multi-Center Prospective Registry Study (CISL 1404)open access

Cho, Hyungwoo; Yoon, Dok Hyun; Shin, Dong-Yeop; Yoon, Sung-Soo; Kim, Seok Jin; Do, Young Rok; Lee, Gyeong-Won; Jae-Yong, Kwak; Park, Yong; Kim, Min Kyoung, et al.

ArticleIssue Date2019CitationBlood, v.134PublisherAmerican Society of Hematology
SCIESCOPUS
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study

Kim, Do Young; Shin, Ho-Jin; Min, Chang-Ki; Eom, Hyeon-Seok; Jung, Jongheon; Kim, Kihyun; Lee, Jae Hoon; Yoo, Kwai Han; Lee, Ji Yun; Byun, Ja Min, et al.

ArticleIssue Date2023CitationClinical Lymphoma, Myeloma and Leukemia, v.23, pp S189 - S190PublisherCancer Media Group
SCIESCOPUS
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Canceropen access

Kim, Ji-Won; Lee, Keun-Wook; Kim, Kyu-Pyo; Lee, Ju Hyun; Hong, Yong Sang; Kim, Jeong-Eun; Kim, Sun Young; Park, Sook Ryun; Nam, Byung-Ho; Cho, Sang-Hee, et al.

ArticleIssue Date2017CitationONCOLOGIST, v.22, no.3, pp 293 - 303PublisherWILEY
SCIESCOPUS
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

Lee, Jeeyun; Park, Se Hoon; Chang, Heung-Moon; Kim, Jun Suk; Choi, Hye Jin; Lee, Myung Ah; Jang, Joung Soon; Jeung, Hei Cheul; Kang, Jung Hun; Lee, Hyun Woo, et al.

ArticleIssue Date2012CitationLANCET ONCOLOGY, v.13, no.2, pp 181 - 188PublisherELSEVIER SCIENCE INC
SCIESCOPUS
Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma studyopen access

Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Lee, Suee; Lee, Dae Ho; Won, Jong-Ho; Hwang, In Gyu; Kim, Min Kyoung; Lee, Soon Il, et al.

ArticleIssue Date2010CitationINTERNATIONAL JOURNAL OF HEMATOLOGY, v.92, no.3, pp 510 - 517PublisherSPRINGER JAPAN KK
SCISCIESCOPUS
Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)open access

Jo, Jae-Cheol; Lee, Ho Sup; Suh, Cheolwon; Kang, Hye Jin; Kim, Won Seog; Eom, HyeonSeok; Kim, Inho; Shin, Ho-Jin; Park, Yong; Lee, Won Sik, et al.

ArticleIssue Date2019CitationBlood, v.134PublisherAmerican Society of Hematology
SCOPUSESCIKCI
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trialopen access

Seo, Jeongkuk; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Lee, Jae Hoon; Hong, Jun Shik; Lee, Gyeong-Won; Oh, Sung Yong; Lee, Ji-Hyun; Yoon, Dok Hyun, et al.

ArticleIssue Date2017CitationBLOOD RESEARCH, v.52, no.3, pp 200 - 206PublisherKOREAN SOC HEMATOLOGY
SCIESCOPUS
Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 Study

Kim, Do Young; Min, Chang-Ki; Eom, Hyeon-Seok; Jung, Jongheon; Kim, Kihyun; Lee, Jae Hoon; Yoo, Kwai Han; Lee, Ji Yun; Byun, Ja Min; Kim, Sung-Hyun, et al.

ArticleIssue Date2025CitationClinical Lymphoma, Myeloma and Leukemia, v.25, no.12, pp 873 - 884PublisherCancer Media Group
SCISCIESCOPUS
Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Lee, Suee; Lee, Dae Ho; Won, Jong-Ho; Hwang, In Gyu; Kim, Min Kyoung; Lee, Soon Il, et al.

ArticleIssue Date2010CitationCANCER SCIENCE, v.101, no.11, pp 2443 - 2447PublisherWILEY-BLACKWELL
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어